Search Results - "Gleissner, Jochen"

LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial by Ohlmann, Carsten-Henning, Jäschke, Michelle, Jaehnig, Peter, Krege, Susanne, Gschwend, Jürgen, Rexer, Heidrun, Junker, Kerstin, Zillmann, Roger, Rüssel, Christoph, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Hübner, Andreas, Mathers, Michael, Gleißner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Klier, Jörg, Stöckle, Michael

“…Background Although the benefit of androgen deprivation therapy (ADT) continuation in metastatic castration-resistant prostate cancer (mCRPC) remains…”
Get full text

Efficacy and Safety of Vardenafil for the Treatment of Erectile Dysfunction in Men with Metabolic Syndrome: Results of a Randomized, Placebo‐Controlled Trial by Schneider, Tim, Gleißner, Jochen, Merfort, Frank, Hermanns, Monika, Beneke, Manfred, Ulbrich, Ernst

“…The prevalence of erectile dysfunction (ED) is increased in men with metabolic syndrome compared with the general population. The aim of this study was to…”
Get full text

Der geriatrische Patient in der Urologie by Gleißner, Jochen

Get full text

Adherence enhancing program for patients with metastatic, castration-resistant prostate carcinoma treated with abiraterone acetate plus prednisone: A cluster randomized trial by Suttmann, Henrik, Feyerabend, Susan, Gleissner, Jochen, Hübner, Andreas, Mathes, Tim, Baurecht, Werner, Krützfeldt, Katrin, Sweiti, Hussein

“…Abstract only e16520 Background: Abiraterone acetate plus prednisone (AA+P) is an effective treatment for patients (pts) with metastatic, castration-resistant…”
Get full text

Retrovesical hematoma secondary to clean intermittent self-catheterization by Ubrig, B, Waldner, M, Gleissner, J, Roth, S

Get more information

Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized Trial by Suttmann, Henrik, Gleissner, Jochen, Huebner, Andreas, Mathes, Tim, Baurecht, Werner, Krützfeldt, Katrin, Sweiti, Hussein, Feyerabend, Susan

“…Residual androgen production causes tumor progression in metastatic, castration-resistant prostate cancer (mCRPC) patients. Abiraterone acetate (AA), a prodrug…”
Get full text

Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program by Hellmis, Eva, Schwentner, Christian, Mandel, Philipp, Banek, Séverine, Gleißner, Jochen, Bögemann, Martin

“…Non-metastatic castration-resistant prostate carcinoma (M0CRPC) is associated with an increased risk of progression and mortality, especially if the…”
Get more information

Praxisabgabe in ein Medizinisches Versorgungszentrum by Gleißner, Jochen

Get full text

Toward noninvasive follow-up of low-risk bladder cancer – Rationale and concept of the UroFollow trial by Benderska-Söder, Natalya, Hovanec, Jan, Pesch, Beate, Goebell, Peter J., Roghmann, Florian, Noldus, Joachim, Rabinovich, Juri, Wichert, Katharina, Gleichenhagen, Jan, Käfferlein, Heiko U., Köhler, Christina U., Johnen, Georg, Kernig, Karoline, Hakenberg, Oliver, Jahn, Daniela, Todenhöfer, Tilman, Stenzl, Arnulf, Gleissner, Jochen, Gerwert, Klaus, El-Mashtoly, Samir, Behrens, Thomas, Brüning, Thomas, Schmitz-Dräger, Bernd J.

“…•Randomized trials regarding the use of markers for follow-up of patients with pTa G1/G2 bladder cancer are missing.•Current recommendations might be prone to…”
Get full text

Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial by Ohlmann, Carsten-Henning, Jäschke, Michelle, Jaehnig, Peter, Krege, Susanne, Gschwend, Jürgen, Rexer, Heidrun, Junker, Kerstin, Zillmann, Roger, Rüssel, Christoph, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Hübner, Andreas, Mathers, Michael, Gleißner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Klier, Jörg, Stöckle, Michael

Get full text

Abiraterone acetate plus prednisone (AA+P) without continuing LHRH-therapy in patients with metastatic chemotherapy: Naive castrations-resistant prostate cancer—Results from the SPARE-trial (NCT02077634) by Ohlmann, Carsten Henning, Ruessel, Christoph, Zillmann, Roger, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Dahm, Johannes, Hübner, Andreas, Gleissner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Jähnig, Peter, Jäschke, Michelle, Klier, Joerg

“…Abstract only 5046 Background: The value of continuation of androgen deprivation therapy (ADT) in metastatic castration-resistant prostate cancer (CRPC)…”
Get full text

Arbeiten jenseits von Rentabilitätsüberlegungen by Gleissner, Jochen

Get full text

Mobile Endgeräte erleichtern den Praxisalltag by Gleißner, Jochen

Get full text

Prospective, non-interventional study on the influence of adherence measures on the therapy with abiraterone acetate (AA) + prednisone/prednisolone (P) in patients with metastatic, castration resistant prostate carcinoma by Suttmann, Henrik, Feyerabend, Susan, Gleissner, Jochen, Huebner, Andreas, Neugebauer, Edmund A.M., Mathes, Tim, Baurecht, Werner, Schuier, Natasha

“…Abstract only…”
Get full text

Urologen brauchen objektive Tests by Gleißner, Jochen

Get full text

Gemeinsam für das Wohl des Patienten: Ambulante Palliativmedizin — Ausbildung und Versorgungsleistung by Gleißner, Jochen

Get full text

Efficacy of abiraterone acetate in the treatment of castration-resistant prostate cancer: Early results from the German compassionate-use program by Ohlmann, Carsten Henning, Stöckle, Michael, Pfister, David A., Heidenreich, Axel, Merseburger, Axel S., Kuczyk, Markus, Manka, Lukas, Hammerer, Peter, Albers, Peter, Arsov, Christian, Retz, Margitta, Gschwend, Jürgen E., Feyerabend, Susan, Stenzl, Arnulf, Banek, Severine, Marin, Jan, Gleissner, Jochen, Wirth, Manfred, Zastrow, Stefan, Heck, Matthias

“…Abstract only e15195 Background: Abiraterone acetate (AA) plus prednisone (P) has demonstrated an improved survival of patients with castration-resistant…”
Get full text

Qualifizierte Beratung für Inkontinenzhilfsmittel by Manseck, Andreas, Piotrowski, Alexander, Butea-Bocu, Marius, Foller, Susan, Gleissner, Jochen, Kahlmeyer, Andreas, Karstedt, Heinrich, Kirschner-Hermanns, Ruth, Liebald, Timo, Linné, Clemens, Moll, Volker, Otto, Ullrich, Schorn, Alexander, Stein, Joachim, Wagner, Arnold, Wiedemann, Andreas

“…Eine Untersuchung der Stiftung Warentest im Jahr 2017 stellte wesentliche Schwachstellen bei der Beratung und nachfolgend ein massives Versorgungsdefizit bei…”
Get full text

Procare : das forbildungsmagazin fur pflegeberufe by Manseck, Andreas, Piotrowski, Alexander, Butea-Bocu, Marius, Foller, Susan, Gleissner, Jochen, Kahlmeyer, Andreas, Karstedt, Heinrich, Kirschner-Hermanns, Ruth, Liebald, Timo, Linné, Clemens, Moll, Volker, Otto, Ullrich, Schorn, Alexander, Stein, Joachim, Wagner, Arnold, Wiedemann, Andreas

Get full text

Qualifizierte Beratung für Inkontinenzhilfsmittel: Das Verbesserungspotenzial ist erheblich by Manseck, Andreas, Piotrowski, Alexander, Butea-Bocu, Marius, Foller, Susan, Gleissner, Jochen, Kahlmeyer, Andreas, Karstedt, Heinrich, Kirschner-Hermanns, Ruth, Liebald, Timo, Linné, Clemens, Moll, Volker, Otto, Ullrich, Schorn, Alexander, Stein, Joachim, Wagner, Arnold, Wiedemann, Andreas

“…Zusammenfassung Eine Untersuchung der Stiftung Warentest im Jahr 2017 stellte wesentliche Schwachstellen bei der Beratung und nachfolgend ein massives…”
Get full text